Brokerages forecast that Walgreens Boots Alliance Inc (NASDAQ:WBA) will report $1.55 earnings per share for the current fiscal quarter, according to Zacks. Ten analysts have provided estimates for Walgreens Boots Alliance’s earnings, with estimates ranging from $1.46 to $1.59. Walgreens Boots Alliance posted earnings per share of $1.36 in the same quarter last year, which would suggest a positive year over year growth rate of 14%. The business is expected to report its next earnings report before the market opens on Wednesday, March 28th.
According to Zacks, analysts expect that Walgreens Boots Alliance will report full-year earnings of $5.79 per share for the current year, with EPS estimates ranging from $5.55 to $5.95. For the next year, analysts expect that the company will report earnings of $6.43 per share, with EPS estimates ranging from $6.05 to $6.74. Zacks’ earnings per share averages are an average based on a survey of research firms that that provide coverage for Walgreens Boots Alliance.
Walgreens Boots Alliance (NASDAQ:WBA) last posted its earnings results on Thursday, January 4th. The pharmacy operator reported $1.28 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.27 by $0.01. Walgreens Boots Alliance had a net margin of 3.19% and a return on equity of 19.15%. The firm had revenue of $30.74 billion during the quarter, compared to analyst estimates of $30.39 billion. During the same quarter in the prior year, the business posted $1.10 EPS. The business’s revenue was up 7.9% compared to the same quarter last year.
WBA has been the subject of several recent analyst reports. Bank of America initiated coverage on shares of Walgreens Boots Alliance in a research note on Tuesday, February 27th. They issued a “neutral” rating and a $76.00 target price for the company. Deutsche Bank initiated coverage on shares of Walgreens Boots Alliance in a research note on Monday, December 4th. They issued a “hold” rating and a $78.00 target price for the company. Zacks Investment Research upgraded shares of Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $76.00 target price for the company in a research note on Wednesday, February 14th. BidaskClub lowered shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research note on Wednesday, February 28th. Finally, ValuEngine upgraded shares of Walgreens Boots Alliance from a “hold” rating to a “buy” rating in a research note on Thursday, January 4th. One research analyst has rated the stock with a sell rating, eleven have assigned a hold rating, eleven have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average price target of $84.75.
In other Walgreens Boots Alliance news, insider Stefano Pessina acquired 98,858 shares of the company’s stock in a transaction on Monday, January 15th. The shares were acquired at an average cost of $76.07 per share, with a total value of $7,520,128.06. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 14.80% of the stock is owned by corporate insiders.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Westside Investment Management Inc. lifted its holdings in shares of Walgreens Boots Alliance by 10.4% in the second quarter. Westside Investment Management Inc. now owns 1,325 shares of the pharmacy operator’s stock worth $102,000 after buying an additional 125 shares in the last quarter. Zions Bancorporation lifted its holdings in shares of Walgreens Boots Alliance by 983.3% in the third quarter. Zions Bancorporation now owns 1,365 shares of the pharmacy operator’s stock worth $105,000 after buying an additional 1,239 shares in the last quarter. Financial Advocates Investment Management purchased a new stake in shares of Walgreens Boots Alliance in the fourth quarter worth about $125,000. Fieldpoint Private Securities LLC lifted its holdings in shares of Walgreens Boots Alliance by 428.6% in the fourth quarter. Fieldpoint Private Securities LLC now owns 1,850 shares of the pharmacy operator’s stock worth $134,000 after buying an additional 1,500 shares in the last quarter. Finally, IHT Wealth Management LLC lifted its holdings in shares of Walgreens Boots Alliance by 46.3% in the second quarter. IHT Wealth Management LLC now owns 6,946 shares of the pharmacy operator’s stock worth $135,000 after buying an additional 2,199 shares in the last quarter. 60.12% of the stock is currently owned by institutional investors and hedge funds.
Shares of Walgreens Boots Alliance (NASDAQ WBA) opened at $70.60 on Friday. Walgreens Boots Alliance has a one year low of $63.82 and a one year high of $87.79. The company has a quick ratio of 0.47, a current ratio of 0.96 and a debt-to-equity ratio of 0.48. The stock has a market cap of $69,940.00, a price-to-earnings ratio of 19.50, a PEG ratio of 1.14 and a beta of 1.21.
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 12th. Shareholders of record on Thursday, February 15th will be issued a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 2.27%. The ex-dividend date is Wednesday, February 14th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently 44.20%.
ILLEGAL ACTIVITY NOTICE: This news story was originally posted by Enterprise Leader and is the property of of Enterprise Leader. If you are viewing this news story on another publication, it was stolen and republished in violation of United States and international copyright laws. The correct version of this news story can be viewed at https://theenterpriseleader.com/2018/04/02/walgreens-boots-alliance-inc-wba-expected-to-post-earnings-of-1-55-per-share.html.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.